Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 14 years
- Director since
- 2023
14 years of board service in total across 4 boards, counting each seat separately. Longest: GridAI Technologies Corp., 3 years.
GridAI Technologies Corp.
Director
Relmada Therapeutics Inc.
Director
Eton Pharmaceuticals Inc.
Director
GT Biopharma Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 22, 2024 | Relmada Therapeutics Inc. | Gift | −13,000 | — | — |
| Sep 9, 2024 | Relmada Therapeutics Inc. | Open-market purchase | +13,000 | $2.56 | $33,280 |
| Jan 2, 2024 | GridAI Technologies Corp. | Grant or award | +19,633 | — | — |
| Sep 15, 2023 | GridAI Technologies Corp. | Open-market sale | −10 | $0.43 | $4 |
| Aug 31, 2023 | GridAI Technologies Corp. | Open-market sale | −6,053 | $0.30 | $1,816 |
| Jan 3, 2023 | GridAI Technologies Corp. | Grant or award | +84,745 | — | — |
| Dec 3, 2021 | Relmada Therapeutics Inc. | Gift | −10,000 | — | — |
| Dec 3, 2021 | Relmada Therapeutics Inc. | Gift | +10,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.